Intro: Wk 1 Flashcards

1
Q

pharmacology

A

-Study of how drugs interact with body to produce therapeutic effects
-Effect of drugs on living systems
-Complex science that requires knowledge of biochem, physio, orgo and molecular bio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

drug + what are namings for the drug

A

-Anything used to treat, dx or prevent disease

What’s in a name? (Ex – Tylenol):
-Chemical name: N-acetyl-p-aminophenol
-Generic: acetaminophen
-Brand (commercial): Tylenol
-Abbreviation: APAP
-Classification of drugs:
-May be based on structure, mechanism of action or the effects it produces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Drug Control and Development

A

1906 – Pure Food and Drug Act (free for all- opiates in everything)
• 1938 – Food, Drug and Cosmetic Act (eyeliner- women losing eyesight, need for safety of pt.)
New drug Application (NDA) – must be submitted to FDA before drug can be marketed
1962 – Efficacy data required→was no safety data or evidence that things worked submitted w/ any commonly used medication + had few medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

clinical testing of drugs

A

-phase 1 – clinical pharmacology: establishes safety
-Phase II – clinical investigations: HUMANS*/animals, establishes efficacy and dose
-Phase III – clinical trials: checks adverse effects
-Phase IV – post marketing studies

PITP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

drug measurements

A

Metric System: (ml, L, kg,g)
Apothecary System: (grains grams oz)
Avoirdupois System: (mass of pounds and oz)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

1kg= _____lb

A

2.2lb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

1tsp is how many ccs
1 tbsp is how many ccs

A

5ccs
15ccs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

pharmacodynamics

A

*** What a DRUG does to the BODY – how they work

  • Biochemical & physiological effects of drugs and mechanisms of action (MOA)

Bts song - Dynamics MOA -> D MOA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Dose-response curve

A

-ideal dose response curve: action increases as concentration increases -> S curve

Shows increasing probability of a certain drug effect as dose level rises

More drug= greater response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

pharmacokinetics

A

What BODY does to DRUG

-How body absorbs, distributes, metabolizes, excretes

ADME

-IV is 100%
-95% of drugs are systemically distributed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pharmacotherapeutics + Risk-benefit ratio

A

-Prevention and treatment of disease

-Risk-benefit ratio* -> how SAFE is a drug:
-Used to describe adverse effects of drug in relation to its beneficial
effects
-Acceptability of ratio depends on severity of disease being treated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

examples of benefits vs adverse effects

A

Benefits:
-Reduce morbidity
-improve quality of life
- effectiveness of drug,
- ease of administration- (such as tablet form)

Adverse:
- Cost
- inconvenience of administration- (such as injection)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

toxicology

A

Study of poisons (recognition, treatment, prevention)

Drugs:
- Adverse drug reactions (ADRs) or side effects (SEs) at therapeutic doses
- Adverse events can end up becoming medications: Viagra/rogaine
- Toxicity at higher doses

Chemicals: NOT used in therapy (household, industrial, environmental, drugs of abuse)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Teratology

A

“The study of monsters”
–How drugs taken during pregnancy can cause fetal morphology

Ex: retinols (Accutane - category x), thalidomide – you have no effect but your female child will have the effect

-category A, B, C, D, X (worst) -> some drugs can change category based on trimester

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Category of Drugs and Pregnancy

A

A safest
X causes teratogen
A- D increases in harm/ unknown harm

A: No risk to fetus
B: Possible effect on fertility but no evidence of risk in first trimester or later trimesters
C: Adverse effects shown on animal testing, only give drugs if potential benefit justifies potential risk to fetus
D: Positive evidence of human fetal risk, use only in life threatening situations
X: Fetal abnormalities and fetal risk; contraindicated in women who are/may become pregnant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Therapeutic Index (TI)

A

TI: margin of safety
-Drugs with a high TI are “safe”
-Drugs with a low TI are “not safe” – usually require therapeutic blood level monitoring

ED: effective dose -> lowest dose with effect

Humans: TD1/ED1
- Minimum toxic dose/minimum therapeutic dose

In animals LD50/ED50 -> lethal dose / effective dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

drugs with low TI

A

Digoxin
lithium
AMG,
Vanco
Phenytoin
Carbamazipine
Warfarin

= Less safe -> usually require therapeutic monitoring!!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How do drugs work?

A

-Drug goes to site of action (biologic molecule) = RECEPTOR
-Receptor may be: membrane, membrane protein, cytoplasmic or extracellular enzyme

-Drug binding site: proteins, glycoproteins or lipoproteins
-Specificity – receptor must be able to recognize a drug for it to work
-Lock & Key - drug-receptor complex
-Drug-receptor complex – produce a biochemical or physiological response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

effects of drug binding

A

-Release of neurotransmitter
-Release of hormone
-Release endogenous chemicals
-Change electrical potential
-Changes membrane permeability
-Cause cascade effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Partial agonist

A

has affinity but low efficacy
-butorphenol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

duration of action

A

-one a day- long duration of action
-4 times a day- short duration of action -> low affinity to receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

agonists

A
  • Drug that combines with a receptor and activates that receptor, produces same response and causes release of chemical
  • Has affinity (tendency for drug to bind) for a receptor and efficacy (ability to produce desired or intended result)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

antagonist

A

-Drug that combines with a receptor used by an endogenous chemical and blocks or diminishes the response of the endogenous agent
-Drug that inhibits the release of an endogenous compound.
-Drug that intercepts the signal generated by an endogenous agent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Competitive vs noncompetitive antagonist

A

-Competitive Antagonism – agonist and antagonist compete for the same
receptor site
-Non-competitive antagonism – agonist and antagonist bind at different sites on the same receptor
-low doses it works -> high doses it loses effects
-often pain pills

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

potency vs efficacy

A

-Potency: If the dose of drug A is less than drug B to achieve the same response –> Drug A is more
potent (1mg vs. 100mg)
-high dose drugs are not potent
-Efficacy: The magnitude of the maximum effect (predefined) -> relative to a person -> maximal effect in a person

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Potency

A

Amount of drug needed for the same effect

Drugs with high specificity and affinity for binding site would you need less of the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

If the dose of drug A is 1mg is less than drug B 100mg and they achieve the same response, which is more potent?

A

DRUG A is MORE potent

-Drug A more potent bc less of drug causes same effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

efficacy

A

The magnitude of the maximum effect

2 different drugs , Drug A 5mg Drug B 5mg
lower effect of drug A, lower efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

tolerance

A

-Reduced response to the same dose or increased dose needed for
the same response

Causes:
-Change in receptor sensitivity
-Change in pharmacokinetics of
drug
-Usually happens slowly, depends on the drug, some do and some
don’t.
-ex: Narcotics, Nitroglycerin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

dependence

A

-Need for the drug- psychological or physiological
-Don’t confuse tolerance with
dependence or addiction

31
Q

placebo effect

A

-psychological response
-well designed clinical trial will contain a placebo group

32
Q

4 categories of allergy (hypersensitivity)

A

-An adverse immune reaction that results from a previous exposure to a
particular chemical or one that is structurally similar

-Divided into 4 categories: “ACID”
-Type I - Anaphylactic
-Type II - Circulatory
-Type III - Inflammatory
-Type IV - Delayed

33
Q

Drug examples that can cause 4 categories of allergies

A

Type 1 anaphylactic: penicillin
Type II circulatory: quinidine, methyldopa
Type III inflammatory: sulfonamide antibiotics (bactrim)
Type IV Delayed: poison ivy, antibiotics, benzocaine

34
Q

allergy type 1

A

-anaphylactic reactions mediated by IgE antibodies**
-symptoms are result of release of histamine, prostaglandins
and leukotrienes

-main symptoms: red, flushed, cant breathe asthmatic, high HR

-Symptoms include: urticaria, rash, vasodilation, hypotension, edema, inflammation, rhinitis, asthma, tachycardia, etc.

-ex. Penicillin

35
Q

allergy type 2

A

Cytolytic reactions mediated by IgG and IgM antibodies that affect the cells of the CIRCULATORY system
- these autoimmune reactions to drugs usually subside within several months after drug discontinuation

Symptoms:
- hemolytic anemia
thrombocytopenia
granulocytopenia
-usually subside within several months after drug discontinuation
-ex. quinidine, methyldopa

36
Q

allergy type 3

A

Arthus reactions are IgG mediated where immune complexes* are deposited in vascular endothelium -> destructive inflammatory response called SERUM SICKNESS occurs here

-general malaise

Symptoms:
- erythema multiforme
- arthritis
- nephritis
- CNS abnormalities
- myocarditis
- SLE (lupus)
- Steven-Johnson Syndrome
-ex. sulfonamide antibiotics (bactrim)

37
Q

allergy type 4

A

DELAYED hypersensitivity reactions mediated by T-lymphocytes and macrophages* (not immunoglobulin)
-When sensitized cells come in contact with the antigen -> lymphokines cause inflammatory reaction
-ex. poison ivy, antibiotics, benzocaine

38
Q

idiosyncratic rxns

A

-unusual response to drug: ex - kids getting energy instead of sleep from Benadryl

Causes:
-genetic difference in metabolism
-immunologic mechanisms

39
Q

Hyperreactive vs Hyporeactive

A

-Hyperreactive- intensity of a given dose of drug is greater than
anticipated
-Hyporeactive- intensity of a given dose of drug is less than expected
- not everyone reacts the same way: could be genetic or based on ethnicity.

40
Q

when is reactivity a concern?

A

-Therapeutic effect not observable
-important with low TI meds
-underdosing – can be as lethal as overdosing
-What can you do?? ->
-Blood levels
-Plasma levels

41
Q

pharmacokinetics 4 aspects: what happens to drug and how it affects the body

A

“ADME”

-absorption
-distribution
-metabolism
-excretion

42
Q

what is a membrane

A

-lipid bilayer
-made of phospholipids and cholesterol
-drugs with higher lipid solubility cross membranes more readily

43
Q

How do drugs cross?

A

-passive diffusion = MC*
-Facilitated diffusion- passes with gradient but requires carrier protein.
-Active transport- against gradient and requires energy (requires ATP)
-Pinocytosis- formation and movement of vesicles (packages) across membranes -> requires energy

44
Q

passive diffusion

A

-MC
-Most drugs pass through membranes by this mechanism
-Diffuse down the concentration gradient (from high to low)
-For non-electrolytes it is proportional to lipid solubility
-For electrolytes it is related to pH

45
Q

absorption

A

-rate at which a drug leaves its site of administration and the extent to which it occurs

46
Q

bioavailability

A

-extent (%) to which a drug reaches its site of action or a biological fluid that has access to that site
- (quantity of drug reaching circulation)/(quantity of drug administered)

-ex: the oral bioavailability of acetaminophen is 90%)
-may be due to the way an oral dosage form is formulated (i.e. very hard tablets don’t dissolve)
-Bioavailability = (Qty Drug reaching Circ) / (Qty Drug Administered)
-IV bioavailability is 100%

47
Q

first pass effect

A

-Drugs that are well absorbed from the G.I. tract and are metabolized
in the liver, have decreased bioavailability as a result of the First-Pass Effect
-liver takes remaining not absorbed

48
Q

factors that modify absorption

A
  • solubility of drug (solutions > suspensions > capsules> tablets)
    -gastric emptying time -> faster gastric time -> less bioavailability (younger) vs slower gastric time -> higher bioavailability (older)
    -Circulation at site: diseases that have poor circulation may not get effect of drug, ie DM
    -Absorbing surface area
    -Transport proteins (P-glycoprotein): can increase or decrease absorption due to gastric emptying time
    -intestinal motility
    -food

“GIFTS - SC”
- gastric emptying time
- intestinal motility
- food
- transport proteins
- Surface area
- solubility of drug
- circulation

49
Q

routes of administration: enteral

A

Oral (PO):
- safest, cheapest, easiest*
-absorption of PO drugs occurs in first 1/3 of small intestine
-BUT some drugs cant be absorbed:
-too irritating
- destroyed by acids or enzymes in GI
- altered by foods or chemicals

Sublingual (SL):
- used for very highly lipid soluble or potent drugs

Rectal (PR)
- only useful when oral is not possible
-elderly, pediatric, when pt is unconscious or has nausea or vomiting
-most drugs are irritating to rectal mucosa and their absorption is unpredictable and variable*

50
Q

routes of administration: Parenteral

A

Fastest to slowest:
1) IV- no absorption phase -> accurate, immediate, irreversible, must be AQUEOUS
2) IM- onset is slower and duration is longer than IV -> absorption is delayed and is related to vascularity
3) SQ, SC- onset is slowest and duration is longest compared to IM bc fat is less vascular than muscle

51
Q

routes of administration: miscellaneous

A

Topical- local drug effect -> creams, lotions etc.

Transdermal- unique delivery system -> drug crosses skin and enter circulation for systemic effect

Aerosol- very rapid onset -> extremely large SA for absorption and good blood supply -> used mostly for local effect

52
Q

distribution

A

Distribution: the delivery of drug from circulation to tissues

Volume of Distribution
-Movement of drug through compartments (BBB and placental barrier)
-represents the degree to which a drug is distributed in the body’s tissues compared to the plasma

53
Q

Distribution: factors that affect efficiency of the movement across the membrane

A

-lipid and protein content
- pH
- osmotic pressure
- blood supply

54
Q

What can affect distribution?

A

Protein binding affects drug distribution!!
-protein binding sites are sometimes referred to as RESEVOIRS*
-binding of drug to protein may significantly affect its bioavailability
-DRUGS THAT ARE BOUND TO ANYTHING (other than a receptor) ARE INACTIVE***
-Drugs must be free or unbound to be active

55
Q

blood brain barrier

A

-selective membrane separating the blood from CSF and brain -> more RESTRICTIVE than any other membrane
-brain is highly lipophilic
-some drugs will concentrate in the brain: CNS depressants
- other drugs may be completely excluded: many antibiotics
-increase inflammation -> increase permeability -> water solubles might be able to cross then (meningitis)

56
Q

placental barrier

A

-membranes separating the blood from the placenta are LESS RESTRICTIVE than most other membranes
-As a result, drugs pass quite easily to the developing fetus.
-Assume all drugs will cross

“what mom gets baby gets”

57
Q

biotransformation / metabolism

A

-Body tries to convert any chemical into one that is INACTIVE and WATER SOLUBLE, so that it can be excreted (pee and poo)
-Most, but not all, biotransformations occur in the liver

58
Q

Classification of biotransformation

A

Phase 1:non-synthetic
- oxidation (cyt P450 mixed fxn oxidases)
- reduction
-hydrolysis

Phase 2- synthetic
-conjugation (glucuronidation, sulfonation)
-joining of the drug with another substance to increase water solubility

-both phases are enzymatic rxns
-goal: make lipophilic drugs to hydrophillic compounds so it can be excreted
-occur primarily in liver but may occur in GI tract, lung, skin or kidneys

59
Q

cytochrome P450 (CYP450) enzymes

A

-main phase I enzyme system involvedin the OXIDATIVE METABOLISM of drugs,
chemicals and some endogenous
substances
-Comprised of many isoforms, each with its own substrate specificity:
-CYP3A4 – predominant isoform: 50% of CYP-mediated metabolism ** (MC!!)
-CYP2D6 – second most common isoform: 30% of CYP-mediated metabolism,
-CYP2C9 – third most common isoform: 10%

60
Q

CYP isoforms and their substrates

A

-CYP3A4: benzos, HIV drugs, calcium channel blockers **
-CYP2D6:psychotropics, codeine, beta-blockers
-CYP2C9: phenytoin, warfarin, NSAIDs

61
Q

Regulation of the CYP450 system

A

Enzyme Inhibitors: slow down metabolism of other drugs metabolized by CYP450 AND INCREASED RXN OF DRUG

Enzyme Inducers: speed up metabolism of other drugs metabolized by CYP450 AND DECREASE DRUG EFFECT

62
Q

pharmacogenetics and pharmacogenomics

A

-terms may be used interchangeably
-Pharmacogenomics - general study of all of the many different genes that determine drug behavior
- broader: encompasses whole genome’s influence on drug response
-Pharmacogenetics - study of inherited differences (variation) in drug metabolism and response
- more narrowly focused on single genes

-applications of pharmogenomics:
-study genes which encode for drug
metabolizing enzymes
-Study genes which encode for defective structural proteins that may result in increased susceptibility to disease

63
Q

single nucleotide polymorphisms (SNPs)

A

-variations in the human genome
-a response to a drug is often linked to these DNA variations
-susceptibility to certain diseases is also influenced by DNA variations

64
Q

CYP2D6

A

-most studied genetic polymorphism
-Affects METABOLISM of psychotropics, codeine, beta-blockers and antiarrhythmics
-7% of caucasians and 1-3% of African Americans and Asians have defects

65
Q

pharmacogenomics and ethnicity

A

-Alcohol and aldehyde dehydrogenase in Asians is decreased -> increase in cancer in upper respiratory tract
-G6PD deficiency in 14% African
Americans -> RBC hemolysis with sulfa drugs
-N-acetyltransferse -> “slow acetylators” more common in middle east population, therefore increase risk of INH (Isoniazid) induced ADRs -> drug levels are higher in these pts bc they arnt metabolizing it -> adverse reactions

66
Q

advantages of pharmacogenomic research

A

-Determine the genetic basis of drug response in individuals
-Develop individualized drug therapies for treating disease
-Provide tailored drug therapy based on genetically determined effectiveness and ADRs

67
Q

miscellaneous polymorphisms

A

-Transport proteins (P-glycoprotein)
-Drug-receptor alterations

68
Q

excretion

A

Drugs are eliminated from the body either unchanged or as metabolites

Most important routes in humans are:
-Kidney
-Feces - either unabsorbed drug or via biliary excretion
-breast milk

Control of excretion via the kidney is pH related:
-more alkaline urine increases the excretion of weak acid
-more acid urine increases the excretion of weak base

69
Q

Clearance and Steady State

A

-clearance- rate at which drug is eliminated from body

-steady state- when rate of administration = clearance -> as you take more meds you will get closer to steady state -> eventually you will excrete the same amount you take in
-concentration affects steady state

70
Q

half life

A

-(t1/2)
-time it takes for concentration of drug to be reduced by half
-plasma half life
-elimination half life

71
Q

factors affecting pharmacokinetics and pharmacodynamics

A

1) Patient factors modify a drug’s effect and dosage:
-Age
-weight
- gender
- genetics
- underlying disease
- immune status
- psychological
- placebo effect

2) Drug-drug and drug-food interactions

72
Q

Synergism,Potentiation, inhibition, induction, unbinding definitions

A

-synergism- combined effect is greater than the sum -> Ex. augmentin

-potentiation - an inactive drug increases the effect of another
-Induction - one drug increases the drug-metabolizing enzyme activity of another

-Inhibition - metabolism or excretion of one drug is blocked by another

-Unbinding - one drug displaces another from a protein binding site. (More unbound drug = more activity)

73
Q

drug safety in pregnancy*

A

-Category A: safest
-Category B
-Category C
-Category D
-Category X

74
Q

article to read

A

genomics